Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 43: 2012-2013, 1997;
This Article
Right arrow Full Text
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Okazaki, T.
Right arrow Articles by Langlois, M. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Okazaki, T.
Right arrow Articles by Langlois, M. R.
Related Collections
Right arrow Molecular Diagnostics and Genetics
Right arrow Hematology
(Clinical Chemistry. 1997;43:2012-2013.)
© 1997 American Association for Clinical Chemistry, Inc.


Letters to the Editor

Difference in Hemoglobin-Binding Ability of Polymers Among Haptoglobin Phenotypes

Toshio Okazaki1,2,1 and Tatsuo Nagai1

1 Dept. of Forensic Sci., School of Allied Health Sci., Kitasato Univ., 1-15-1 Kitasato, Sagamihara City, 228 Japan ,
2 Dept. of Biochem., Mitsubishi Kagaku Bio-Clin. Labs., Inc., Shimura 3-30-1, Itabashi-ku, Tokyo, 174 Japan


To the Editor:

Langlois and Delanghe (1) described several functional differences between haptoglobin phenotypes in this journal. They reviewed the functional properties of haptoglobin phenotypes such as ability for hemoglobin (Hb) binding, antioxidative capacity, and inhibition of prostaglandin synthesis, which were strong in Hp-1, intermediate in Hp2–1, and weak in Hp2–2. However, we do not agree with their results about the ability for Hb binding.

Hp2–1 and Hp2–2 phenotypes form many polymers, and analysis of the functional properties of each of the isolated polymer proteins had been very difficult (2). We designed new analytical methods such as crossed Hb electrophoresis (3) and two-dimensional affinity electrophoresis, using Hb (4) to identify the Hb-binding ability of each of the haptoglobin polymer proteins of Hp2–1 and Hp2–2 phenotypes. From the results of crossed Hb electrophoresis, we found that a haptoglobin molecule combined with equimolar amounts of Hb to form at least a hexamer. We confirmed by two-dimensional affinity electrophoresis that the larger polymer of the Hp2–2 phenotype had a lower affinity to Hb, but a . . . [Full Text of this Article]


Footnotes


References

Joris R. Delanghe and Michel R. Langlois

Dept. of Clin. Chem., University Hosp. Gent, De Pintelaan 185, B 9000 Gent, Belgium
a Author for correspondence.


To the Editor:


References




The following articles in journals at HighWire Press have cited this article:


Home page
Am J Trop Med HygHome page
H. IMRIE, F. J.I. FOWKES, P. MICHON, L. TAVUL, J. C.C. HUME, K. P. PIPER, J. C. REEDER, and K. P. DAY
HAPTOGLOBIN LEVELS ARE ASSOCIATED WITH HAPTOGLOBIN GENOTYPE AND {alpha}+-THALASSEMIA IN A MALARIA-ENDEMIC AREA
Am J Trop Med Hyg, June 1, 2006; 74(6): 965 - 971.
[Abstract] [Full Text] [PDF]


Home page
Am J Trop Med HygHome page
F. J. I. FOWKES, H. IMRIE, F. MIGOT-NABIAS, P. MICHON, A. JUSTICE, P. DELORON, A. J. F. LUTY, and K. P. DAY
ASSOCIATION OF HAPTOGLOBIN LEVELS WITH AGE, PARASITE DENSITY, AND HAPTOGLOBIN GENOTYPE IN A MALARIA-ENDEMIC AREA OF GABON
Am J Trop Med Hyg, January 1, 2006; 74(1): 26 - 30.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
S. Mustafa, T. Vukovich, T. Prikoszovich, C. Winzer, B. Schneider, H. Esterbauer, O. Wagner, and A. Kautzky-Willer
Haptoglobin Phenotype and Gestational Diabetes
Diabetes Care, September 1, 2004; 27(9): 2103 - 2107.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1997 by the American Association for Clinical Chemistry.